Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Emotion-modulated startle reflex during reappraisal: Probe timing and behavioral correlates.

Zaehringer J, Schmahl C, Ende G, Paret C.

Behav Neurosci. 2018 Dec;132(6):573-579. doi: 10.1037/bne0000271. Epub 2018 Oct 4.

PMID:
30284860
2.

Intrinsic connectivity network dynamics in PTSD during amygdala downregulation using real-time fMRI neurofeedback: A preliminary analysis.

Nicholson AA, Rabellino D, Densmore M, Frewen PA, Paret C, Kluetsch R, Schmahl C, Théberge J, Ros T, Neufeld RWJ, McKinnon MC, Reiss JP, Jetly R, Lanius RA.

Hum Brain Mapp. 2018 Nov;39(11):4258-4275. doi: 10.1002/hbm.24244. Epub 2018 Jul 13.

PMID:
30004602
3.

Shuffling the neutral drift of unspecific peroxygenase in Saccharomyces cerevisiae.

Martin-Diaz J, Paret C, García-Ruiz E, Molina-Espeja P, Alcalde M.

Appl Environ Microbiol. 2018 May 18. pii: AEM.00808-18. doi: 10.1128/AEM.00808-18. [Epub ahead of print]

4.

Monitoring and control of amygdala neurofeedback involves distributed information processing in the human brain.

Paret C, Zähringer J, Ruf M, Gerchen MF, Mall S, Hendler T, Schmahl C, Ende G.

Hum Brain Mapp. 2018 Jul;39(7):3018-3031. doi: 10.1002/hbm.24057. Epub 2018 Mar 30.

PMID:
29602255
5.
6.

Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.

Paret C, Russo A, Otto H, Mayer A, Zahnreich S, Wagner W, Samuel D, Scharnhorst D, Solomon DA, Dhall G, Wong K, Bender H, Alt F, Wingerter A, Neu MA, Beck O, Prawitt D, Eder S, Henninger N, El Malki K, Lehmann N, Backes N, Roth L, Seidmann L, Sommer C, Brockmann MA, Staatz G, Schmidberger H, Faber J.

Oncotarget. 2017 Dec 11;8(69):114210-114225. doi: 10.18632/oncotarget.23174. eCollection 2017 Dec 26.

7.

Abstracts of the 52nd Workshop for Pediatric Research : Frankfurt, Germany. 27-28 October 2016.

van den Bruck R, Weil PP, Ziegenhals T, Schreiner P, Juranek S, Gödde D, Vogel S, Schuster F, Orth V, Dörner J, Pembaur D, Röper M, Störkel S, Zirngibl H, Wirth S, Jenke ACW, Postberg J, Boy N, Heringer J, Haege G, Glahn EM, Hoffmann GF, Garbade SF, Burgard P, Kölker S, Chao CM, Yahya F, Moiseenko A, Shrestha A, Ahmadvand N, Quantius J, Wilhelm J, El-Agha E, Zimmer KP, Bellusci S, Staufner C, Kölker S, Prokisch H, Hoffmann GF, Seeliger S, Müller M, Hippe A, Steinkraus H, Wauer R, Lachmann B, Hofmann SR, Hedrich CM, Zierk J, Arzideh F, Haeckel R, Rascher W, Rauh M, Metzler M, Thieme S, Bandoła J, Richter C, Ryser M, Jamal A, Ashton MP, von Bonin M, Kuhn M, Hedrich CM, Bonifacio E, Berner R, Brenner S, Hammersen J, Has C, Naumann-Bartsch N, Stachel D, Kiritsi D, Söder S, Tardieu M, Metzler M, Bruckner-Tuderman L, Schneider H, Bohne F, Langer D, Cencic R, Eggermann T, Zechner U, Pelletier J, Zepp F, Enklaar T, Prawitt D, Pech M, Weckmann M, Heinsen FA, Franke A, Happle C, Dittrich AM, Hansen G, Fuchs O, von Mutius E, Oliver BG, Kopp MV, Paret C, Russo A, Theruvath J, Keller B, El Malki K, Lehmann N, Wingerter A, Neu MA, Aslihan GA, Wagner W, Sommer C, Pietsch T, Seidmann L, Faber J, Schreiner F, Ackermann M, Michalik M, Rother E, Bilkei-Gorzo A, Racz I, Bindila L, Lutz B, Dötsch J, Zimmer A, Woelfle J, Fischer HS, Ullrich TL, Bührer C, Czernik C, Schmalisch G, Stein R, Hofmann SR, Hagenbuchner J, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner MJ, Loges NT, Frommer AT, Wallmeier J, Omran H, Öner-Sieben S, Gimpfl M, Rozman J, Irmler M, Beckers J, De Angelis MH, Roscher A, Wolf E, Ensenauer R, Nemes K, Frühwald M, Hasselblatt M, Siebert R, Kordes U, Kool M, Wang H, Hardy H, Refai O, Barwick KES, Zimmerman HH, Weis J, Baple EL, Crosby AH, Cirak S, Hellmuth C, Uhl O, Standl M, Heinrich J, Thiering E, Koletzko B, Blümel L, Kerl K, Picard D, Frühwald MC, Liebau MC, Reifenberger G, Borkhardt A, Hasselblatt M, Remke M, Tews D, Wabitsch M, Fischer-Posovszky P, Westhoff MA, Nonnenmacher L, Langhans J, Schneele L, Trenkler N, Debatin KM.

Mol Cell Pediatr. 2017 May;4(Suppl 1):5. doi: 10.1186/s40348-017-0071-0. No abstract available.

8.

CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.

Fischer J, Paret C, El Malki K, Alt F, Wingerter A, Neu MA, Kron B, Russo A, Lehmann N, Roth L, Fehr EM, Attig S, Hohberger A, Kindler T, Faber J.

J Immunother. 2017 Jun;40(5):187-195. doi: 10.1097/CJI.0000000000000169.

9.

Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.

Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP.

Am J Med Genet A. 2017 Apr;173(4):1017-1037. doi: 10.1002/ajmg.a.38142. Epub 2017 Feb 7. Review.

PMID:
28168833
10.

Disadvantageous decision-making in borderline personality disorder: Partial support from a meta-analytic review.

Paret C, Jennen-Steinmetz C, Schmahl C.

Neurosci Biobehav Rev. 2017 Jan;72:301-309. doi: 10.1016/j.neubiorev.2016.11.019. Epub 2016 Nov 30. Review.

PMID:
27914943
11.

Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.

Paret C, Theruvath J, Russo A, Kron B, El Malki K, Lehmann N, Wingerter A, Neu MA, Gerhold-Ay A, Wagner W, Sommer C, Pietsch T, Seidmann L, Faber J.

Oncotarget. 2016 Dec 13;7(50):83378-83391. doi: 10.18632/oncotarget.13092.

12.

The neurobiology of emotion regulation in posttraumatic stress disorder: Amygdala downregulation via real-time fMRI neurofeedback.

Nicholson AA, Rabellino D, Densmore M, Frewen PA, Paret C, Kluetsch R, Schmahl C, Théberge J, Neufeld RW, McKinnon MC, Reiss J, Jetly R, Lanius RA.

Hum Brain Mapp. 2017 Jan;38(1):541-560. doi: 10.1002/hbm.23402. Epub 2016 Sep 20.

PMID:
27647695
13.

Associations of emotional arousal, dissociation and symptom severity with operant conditioning in borderline personality disorder.

Paret C, Hoesterey S, Kleindienst N, Schmahl C.

Psychiatry Res. 2016 Oct 30;244:194-201. doi: 10.1016/j.psychres.2016.07.054. Epub 2016 Jul 26.

PMID:
27491014
14.

Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma.

Theruvath J, Russo A, Kron B, Paret C, Wingerter A, El Malki K, Neu MA, Alt F, Staatz G, Stein R, Seidmann L, Prawitt D, Faber J.

Pediatr Hematol Oncol. 2016 May;33(4):264-75. doi: 10.1080/08880018.2016.1184362.

PMID:
27285993
15.

Alterations of amygdala-prefrontal connectivity with real-time fMRI neurofeedback in BPD patients.

Paret C, Kluetsch R, Zaehringer J, Ruf M, Demirakca T, Bohus M, Ende G, Schmahl C.

Soc Cogn Affect Neurosci. 2016 Jun;11(6):952-60. doi: 10.1093/scan/nsw016. Epub 2016 Feb 1.

16.

fMRI neurofeedback of amygdala response to aversive stimuli enhances prefrontal-limbic brain connectivity.

Paret C, Ruf M, Gerchen MF, Kluetsch R, Demirakca T, Jungkunz M, Bertsch K, Schmahl C, Ende G.

Neuroimage. 2016 Jan 15;125:182-188. doi: 10.1016/j.neuroimage.2015.10.027. Epub 2015 Oct 16.

PMID:
26481674
17.

Meta-analysis of real-time fMRI neurofeedback studies using individual participant data: How is brain regulation mediated?

Emmert K, Kopel R, Sulzer J, Brühl AB, Berman BD, Linden DEJ, Horovitz SG, Breimhorst M, Caria A, Frank S, Johnston S, Long Z, Paret C, Robineau F, Veit R, Bartsch A, Beckmann CF, Van De Ville D, Haller S.

Neuroimage. 2016 Jan 1;124(Pt A):806-812. doi: 10.1016/j.neuroimage.2015.09.042. Epub 2015 Sep 28. Review.

PMID:
26419389
18.

CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer.

Paret C, Simon P, Vormbrock K, Bender C, Kölsch A, Breitkreuz A, Yildiz Ö, Omokoko T, Hubich-Rau S, Hartmann C, Häcker S, Wagner M, Roldan DB, Selmi A, Türeci Ö, Sahin U.

Oncotarget. 2015 Sep 22;6(28):25356-67. doi: 10.18632/oncotarget.4516.

19.

Incision and stress regulation in borderline personality disorder: neurobiological mechanisms of self-injurious behaviour.

Reitz S, Kluetsch R, Niedtfeld I, Knorz T, Lis S, Paret C, Kirsch P, Meyer-Lindenberg A, Treede RD, Baumgärtner U, Bohus M, Schmahl C.

Br J Psychiatry. 2015 Aug;207(2):165-72. doi: 10.1192/bjp.bp.114.153379. Epub 2015 Apr 23.

PMID:
25906795
20.

Amygdala and Dorsal Anterior Cingulate Connectivity during an Emotional Working Memory Task in Borderline Personality Disorder Patients with Interpersonal Trauma History.

Krause-Utz A, Elzinga BM, Oei NY, Paret C, Niedtfeld I, Spinhoven P, Bohus M, Schmahl C.

Front Hum Neurosci. 2014 Oct 28;8:848. doi: 10.3389/fnhum.2014.00848. eCollection 2014.

21.

Down-regulation of amygdala activation with real-time fMRI neurofeedback in a healthy female sample.

Paret C, Kluetsch R, Ruf M, Demirakca T, Hoesterey S, Ende G, Schmahl C.

Front Behav Neurosci. 2014 Sep 18;8:299. doi: 10.3389/fnbeh.2014.00299. eCollection 2014.

22.

Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes.

Simon P, Omokoko TA, Breitkreuz A, Hebich L, Kreiter S, Attig S, Konur A, Britten CM, Paret C, Dhaene K, Türeci Ö, Sahin U.

Cancer Immunol Res. 2014 Dec;2(12):1230-44. doi: 10.1158/2326-6066.CIR-14-0108. Epub 2014 Sep 22.

23.

Transient and sustained BOLD signal time courses affect the detection of emotion-related brain activation in fMRI.

Paret C, Kluetsch R, Ruf M, Demirakca T, Kalisch R, Schmahl C, Ende G.

Neuroimage. 2014 Dec;103:522-532. doi: 10.1016/j.neuroimage.2014.08.054. Epub 2014 Sep 7.

PMID:
25204866
24.

Mutated tumor alleles are expressed according to their DNA frequency.

Castle JC, Loewer M, Boegel S, Tadmor AD, Boisguerin V, de Graaf J, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U.

Sci Rep. 2014 Apr 22;4:4743. doi: 10.1038/srep04743.

25.

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.

Castle JC, Loewer M, Boegel S, de Graaf J, Bender C, Tadmor AD, Boisguerin V, Bukur T, Sorn P, Paret C, Diken M, Kreiter S, Türeci Ö, Sahin U.

BMC Genomics. 2014 Mar 13;15:190. doi: 10.1186/1471-2164-15-190.

26.

NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.

Wagner M, Koslowski M, Paret C, Schmidt M, Türeci O, Sahin U.

BMC Cancer. 2013 Dec 4;13:570. doi: 10.1186/1471-2407-13-570.

27.

Confidence-based somatic mutation evaluation and prioritization.

Löwer M, Renard BY, de Graaf J, Wagner M, Paret C, Kneip C, Türeci O, Diken M, Britten C, Kreiter S, Koslowski M, Castle JC, Sahin U.

PLoS Comput Biol. 2012;8(9):e1002714. doi: 10.1371/journal.pcbi.1002714. Epub 2012 Sep 27.

28.

Exploiting the mutanome for tumor vaccination.

Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, Koslowski M, Kuhn AN, Britten CM, Huber C, Türeci O, Sahin U.

Cancer Res. 2012 Mar 1;72(5):1081-91. doi: 10.1158/0008-5472.CAN-11-3722. Epub 2012 Jan 11.

29.

A test for the implementation-maintenance model of reappraisal.

Paret C, Brenninkmeyer J, Meyer B, Yuen KS, Gartmann N, Mechias ML, Kalisch R.

Front Psychol. 2011 Sep 6;2:216. doi: 10.3389/fpsyg.2011.00216. eCollection 2011.

30.

Community benefit: overcoming organizational barriers and laying the foundation for success.

Barsi E, Jones D, Kotsonis D, Lowell M, Paret C, McPherson B.

Inquiry. 2010 Summer;47(2):103-9. No abstract available.

PMID:
20812459
31.

Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome.

Paret C, Schön Z, Szponar A, Kovacs G.

Eur Urol. 2010 May;57(5):859-66. doi: 10.1016/j.eururo.2009.08.014. Epub 2009 Aug 27.

PMID:
19747761
32.

C4.4A as a candidate marker in the diagnosis of colorectal cancer.

Paret C, Hildebrand D, Weitz J, Kopp-Schneider A, Kuhn A, Beer A, Hautmann R, Zöller M.

Br J Cancer. 2007 Oct 22;97(8):1146-56. Epub 2007 Oct 2.

33.

Novel class of glycosphingolipids involved in male fertility.

Sandhoff R, Geyer R, Jennemann R, Paret C, Kiss E, Yamashita T, Gorgas K, Sijmonsma TP, Iwamori M, Finaz C, Proia RL, Wiegandt H, Gröne HJ.

J Biol Chem. 2005 Jul 22;280(29):27310-8. Epub 2005 May 25.

34.

Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.

Gesierich S, Paret C, Hildebrand D, Weitz J, Zgraggen K, Schmitz-Winnenthal FH, Horejsi V, Yoshie O, Herlyn D, Ashman LK, Zöller M.

Clin Cancer Res. 2005 Apr 15;11(8):2840-52.

35.

Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin-3 and supports cell migration.

Paret C, Bourouba M, Beer A, Miyazaki K, Schnölzer M, Fiedler S, Zöller M.

Int J Cancer. 2005 Jul 10;115(5):724-33.

36.
37.

[Clowns in hospitals or the wonderful story of a successful collaboration].

Paret C.

Rev Infirm. 2002 Nov;(85):41-3. French. No abstract available.

PMID:
12510531
38.

Straight talk: new approaches in healthcare. Rx for reimbursement woes: high-quality medical documentation and coding. Panel discussion.

Armstrong CM, Bryant GH, Cummins RA, Paret CJ, Rutledge KL.

Mod Healthc. 2002 Jul 22;32(29):35-8. No abstract available.

PMID:
12152497
39.
40.

Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts.

Jaksch M, Paret C, Stucka R, Horn N, Müller-Höcker J, Horvath R, Trepesch N, Stecker G, Freisinger P, Thirion C, Müller J, Lunkwitz R, Rödel G, Shoubridge EA, Lochmüller H.

Hum Mol Genet. 2001 Dec 15;10(26):3025-35.

PMID:
11751685
41.

The P(174)L mutation in the human hSCO1 gene affects the assembly of cytochrome c oxidase.

Paret C, Lode A, Krause-Buchholz U, Rödel G.

Biochem Biophys Res Commun. 2000 Dec 20;279(2):341-7.

PMID:
11118289
42.

Mitochondrial copper metabolism in yeast: interaction between Sco1p and Cox2p.

Lode A, Kuschel M, Paret C, Rödel G.

FEBS Lett. 2000 Nov 17;485(1):19-24.

43.

Identification of functionally important regions of the Saccharomyces cerevisiae mitochondrial translational activator Cbs1p.

Krause-Buchholz U, Tzschoppe K, Paret C, Ostermann K, Rödel G.

Yeast. 2000 Mar 15;16(4):353-63.

PMID:
10669873
44.

Human members of the SCO1 gene family: complementation analysis in yeast and intracellular localization.

Paret C, Ostermann K, Krause-Buchholz U, Rentzsch A, Rödel G.

FEBS Lett. 1999 Mar 19;447(1):65-70.

45.

Acetabular labrum: MRI in asymptomatic volunteers.

Cotten A, Boutry N, Demondion X, Paret C, Dewatre F, Liesse A, Chastanet P, Fontaine C.

J Comput Assist Tomogr. 1998 Jan-Feb;22(1):1-7.

PMID:
9448753
46.

[Informing an adolescent cancer patient].

Paret C.

Soins. 1989 Jul-Aug;(526-527):42-3. French. No abstract available.

PMID:
2814611

Supplemental Content

Support Center